Abiopharma

🔍 Herr Amy E. (Director)

Company: BIO-TECHNE Corp (TECH)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: H | shares_owned_after: 2,680.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: H | nature_of_ownership: By significant other | shares_owned_after: 576.00
• Acquired 1,381 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,381.00 | transaction_form_type: 4 | Footnotes: F7, F11, F11
• Holds 4,472 shares of Stock Option (Right to Buy) at $66.97 per share (Derivative)
  Date: 2026-08-17 | Code: H | Expires: 2027-08-05 | shares_owned_after: 4,472.00 | Footnotes: F1
• Holds 2,076 shares of Stock Option (Right to Buy) at $120.46 per share (Derivative)
  Date: 2026-08-17 | Code: H | Expires: 2028-08-06 | shares_owned_after: 2,076.00 | Footnotes: F1
• Holds 2,104 shares of Stock Option (Right to Buy) at $94.52 per share (Derivative)
  Date: 2026-08-17 | Code: H | Expires: 2029-08-15 | shares_owned_after: 2,104.00 | Footnotes: F1
• Holds 1,084 shares of Stock Option (Right to Buy) at $84.61 per share (Derivative)
  Date: 2026-08-17 | Code: H | Expires: 2030-08-15 | shares_owned_after: 1,084.00 | Footnotes: F2
• Holds 1,468 shares of Stock Option (Right to Buy) at $74.91 per share (Derivative)
  Date: 2026-08-17 | Code: H | Expires: 2034-08-15 | shares_owned_after: 1,468.00 | Footnotes: F3
• Holds 2,415 shares of Stock Option (Right to Buy) at $72.05 per share (Derivative)
  Date: 2026-08-17 | Code: H | Expires: 2035-02-03 | shares_owned_after: 2,415.00 | Footnotes: F1
• Holds 344 shares of Stock Option (Right to Buy) at $72.05 per share (Derivative)
  Date: 2026-08-17 | Code: H | Expires: 2035-02-03 | shares_owned_after: 344.00 | Footnotes: F4
• Holds 2,735 shares of Stock Option (Right to Buy) at $53.6 per share (Derivative)
  Date: 2026-08-17 | Code: H | Expires: 2035-08-15 | shares_owned_after: 2,735.00 | Footnotes: F5
• Holds 3,777 shares of Stock Option (Right to Buy) at $60.96 per share (Derivative)
  Date: 2026-08-17 | Code: H | Expires: 2035-10-30 | shares_owned_after: 3,777.00 | Footnotes: F6
• Holds 160 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-17 | Code: H | shares_owned_after: 160.00 | Footnotes: F7, F8, F8
• Holds 77 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-17 | Code: H | shares_owned_after: 77.00 | Footnotes: F7, F9, F9
• Holds 621 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-17 | Code: H | shares_owned_after: 621.00 | Footnotes: F7, F10, F10

Footnotes:

• F1: Fully vested.
• F2: Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
• F3: Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
• F4: Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
• F5: Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028.
• F6: This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
• F7: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
• F8: 160 restricted stock units vest on 8/15/2027.
• F9: 38 restricted stock units vest on 2/3/2027, and 39 restricted stock units vest on 2/3/2028.
• F10: 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028.
• F11: 460 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 461 restricted stock units vest on 8/17/2029.